A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells

Despite significant efforts, vaccines are not yet available for every infectious pathogen, and the search for a protective approach to prevent the establishment of chronic infections, i.e., with HIV, continues. Immune checkpoint therapies targeting inhibitory receptors, such as PD-1, have shown imp...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Torben Knuschke, Sebastian Kollenda, Christina Wenzek, Gennadiy Zelinskyy, Philine Steinbach, Ulf Dittmer, Jan Buer, Matthias Epple, Astrid M. Westendorf
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://doaj.org/article/c4b0311ffd9843a69b3db45c416f2a05
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c4b0311ffd9843a69b3db45c416f2a05
record_format dspace
spelling oai:doaj.org-article:c4b0311ffd9843a69b3db45c416f2a052021-11-03T18:15:37ZA Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells2161-21292150-751110.1128/mBio.02121-20https://doaj.org/article/c4b0311ffd9843a69b3db45c416f2a052021-02-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.02121-20https://doaj.org/toc/2161-2129https://doaj.org/toc/2150-7511 Despite significant efforts, vaccines are not yet available for every infectious pathogen, and the search for a protective approach to prevent the establishment of chronic infections, i.e., with HIV, continues. Immune checkpoint therapies targeting inhibitory receptors, such as PD-1, have shown impressive results against solid tumors.Torben KnuschkeSebastian KollendaChristina WenzekGennadiy ZelinskyyPhiline SteinbachUlf DittmerJan BuerMatthias EppleAstrid M. WestendorfAmerican Society for MicrobiologyarticleMicrobiologyQR1-502ENmBio, Vol 12, Iss 1 (2021)
institution DOAJ
collection DOAJ
language EN
topic Microbiology
QR1-502
spellingShingle Microbiology
QR1-502
Torben Knuschke
Sebastian Kollenda
Christina Wenzek
Gennadiy Zelinskyy
Philine Steinbach
Ulf Dittmer
Jan Buer
Matthias Epple
Astrid M. Westendorf
A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
description Despite significant efforts, vaccines are not yet available for every infectious pathogen, and the search for a protective approach to prevent the establishment of chronic infections, i.e., with HIV, continues. Immune checkpoint therapies targeting inhibitory receptors, such as PD-1, have shown impressive results against solid tumors.
format article
author Torben Knuschke
Sebastian Kollenda
Christina Wenzek
Gennadiy Zelinskyy
Philine Steinbach
Ulf Dittmer
Jan Buer
Matthias Epple
Astrid M. Westendorf
author_facet Torben Knuschke
Sebastian Kollenda
Christina Wenzek
Gennadiy Zelinskyy
Philine Steinbach
Ulf Dittmer
Jan Buer
Matthias Epple
Astrid M. Westendorf
author_sort Torben Knuschke
title A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
title_short A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
title_full A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
title_fullStr A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
title_full_unstemmed A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells
title_sort combination of anti-pd-l1 treatment and therapeutic vaccination facilitates improved retroviral clearance via reactivation of highly exhausted t cells
publisher American Society for Microbiology
publishDate 2021
url https://doaj.org/article/c4b0311ffd9843a69b3db45c416f2a05
work_keys_str_mv AT torbenknuschke acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT sebastiankollenda acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT christinawenzek acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT gennadiyzelinskyy acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT philinesteinbach acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT ulfdittmer acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT janbuer acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT matthiasepple acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT astridmwestendorf acombinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT torbenknuschke combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT sebastiankollenda combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT christinawenzek combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT gennadiyzelinskyy combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT philinesteinbach combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT ulfdittmer combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT janbuer combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT matthiasepple combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
AT astridmwestendorf combinationofantipdl1treatmentandtherapeuticvaccinationfacilitatesimprovedretroviralclearanceviareactivationofhighlyexhaustedtcells
_version_ 1718445482662952960